When Amgen CEO Robert Bradway announced big job cuts in 2014, he explained that part of the slimming would come from manufacturing its protein therapies more efficiently. Part of that job going forward will fall to contract manufacturer Patheon, which said on Monday that it has a new deal to provide "flexible manufacturing solutions" for Amgen.
Morristown, NJ's Capsugel announced it will manufacture inhaled candidates being developed by Pulmatrix.
AMRI, having refocused on its contract manufacturing operations, saw the changes pay off last year, according to its recently released earnings. The Albany, NY-based CDMO reported that revenue grew 45% in 2015, to $402.3 million, up from $276.6 million from the previous year.
Cook Medical is recalling 17,827 single-lumen central venous catheters and pressure monitoring sets and trays because of concerns about catheter tip fracture and/or separation. The FDA posted the Bloomington, IN's company's recall on its website, an action it takes from time to time to publicize recalls that are critical to patient safety.
Years ago, German CDMO Vetter determined that in addition to building out its manufacturing capacity, it needed to expand its IT infrastructure to continue to satisfy clients. Now after two years, Vetter has wrapped up work on a 91,500-square-foot multipurpose facility in Schuetzenstrasse, Germany, that bulks up computing operations.
TxCell, a biotech working on T cell treatments for chronic inflammatory and autoimmune diseases, has signed on Belgium CMO MaSTherCell to produce drugs for the French company's ASTrLA line.
Axxess Pharma, a maker of specialty pharmaceuticals and supplements, has tapped SDC Nutrition to begin manufacturing protein powders.
Contract player Recipharm has been on a buying spree that now takes it into India to expand its reach in sterile injectables, one of the hot areas these days for both drugmakers and contractors.
Regis Technologies, a Morton Grove, IL-based CMO, has opened a new suite for manufacturing highly potent APIs.
Emergent BioSolutions has launched a military-grade intramuscular autoinjector device for self-administered antidotes or other chemical threat treatments. For now, the rollout is only ex-U.S., but the infectious disease specialist said it will seek FDA approval for the device, dubbed Emergard.